Erika Litvin Bloom1,2, Jason A Oliver3,4, Steven K Sutton4,5,6, Thomas H Brandon3,4,6, Paul B Jacobsen3,4,6, Vani Nath Simmons3,4,6. 1. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA. 2. Butler Hospital, Providence, RI, USA. 3. Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center, Tampa, FL, USA. 4. Department of Psychology, University of South Florida, Tampa, FL, USA. 5. Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, FL, USA. 6. Department of Oncologic Sciences, University of South Florida, Tampa, FL, USA.
Abstract
OBJECTIVE: An estimated 35-50% of lung and head and neck cancer patients are smoking at diagnosis; most try to quit; however, a substantial proportion resumes smoking. As cancer treatments improve, attention to the effects of continued smoking on quality of life in the survivorship period is increasing. The current study examines if smoking abstinence following surgical treatment is associated with better quality of life. METHODS: Participants were 134 patients with head and neck or lung cancer who received surgical treatment. Smoking status and indices of quality of life (depressive symptoms, fatigue, and pain) were assessed at the time of surgery (baseline) and at 2, 4, 6, and 12 months post-surgery. Analyses were performed using a generalized estimating equations approach. A series of models examined the correlation between smoking status and post-surgery quality of life while adjusting for demographics, clinical variables, and baseline smoking status and quality of life. RESULTS: Continuous post-surgery abstinence was associated with lower levels of depressive symptoms and fatigue; however, the relationship with fatigue became nonsignificant after adjusting for baseline fatigue and income. There was no significant relationship observed between smoking status and pain. CONCLUSIONS: Findings add to a growing literature showing that smoking cessation is not associated with detrimental effects on quality of life and may have beneficial effects, particularly with regard to depressive symptoms. Such information can be used to motivate smoking cessation and continued abstinence among cancer patients and increase provider comfort in recommending cessation.
OBJECTIVE: An estimated 35-50% of lung and head and neck cancerpatients are smoking at diagnosis; most try to quit; however, a substantial proportion resumes smoking. As cancer treatments improve, attention to the effects of continued smoking on quality of life in the survivorship period is increasing. The current study examines if smoking abstinence following surgical treatment is associated with better quality of life. METHODS:Participants were 134 patients with head and neck or lung cancer who received surgical treatment. Smoking status and indices of quality of life (depressive symptoms, fatigue, and pain) were assessed at the time of surgery (baseline) and at 2, 4, 6, and 12 months post-surgery. Analyses were performed using a generalized estimating equations approach. A series of models examined the correlation between smoking status and post-surgery quality of life while adjusting for demographics, clinical variables, and baseline smoking status and quality of life. RESULTS: Continuous post-surgery abstinence was associated with lower levels of depressive symptoms and fatigue; however, the relationship with fatigue became nonsignificant after adjusting for baseline fatigue and income. There was no significant relationship observed between smoking status and pain. CONCLUSIONS: Findings add to a growing literature showing that smoking cessation is not associated with detrimental effects on quality of life and may have beneficial effects, particularly with regard to depressive symptoms. Such information can be used to motivate smoking cessation and continued abstinence among cancerpatients and increase provider comfort in recommending cessation.
Authors: Elyse R Park; Sandra J Japuntich; Nancy A Rigotti; Lara Traeger; Yulei He; Robert B Wallace; Jennifer L Malin; Jennifer P Zallen; Nancy L Keating Journal: Cancer Date: 2012-01-23 Impact factor: 6.860
Authors: Joseph W Ditre; Brian D Gonzalez; Vani N Simmons; Leigh Anne Faul; Thomas H Brandon; Paul B Jacobsen Journal: Pain Date: 2011-01 Impact factor: 6.961
Authors: Mary E Cooley; Qian Wang; Bruce E Johnson; Paul Catalano; Robert I Haddad; Raphael Bueno; Karen M Emmons Journal: Lung Cancer Date: 2011-11-16 Impact factor: 5.705
Authors: Henrietta L Logan; Roger B Fillingim; Linda M Bartoshuk; Pamela Sandow; Scott L Tomar; John W Werning; William M Mendenhall Journal: J Pain Date: 2009-12-16 Impact factor: 5.820
Authors: Vani Nath Simmons; Erika B Litvin; Paul B Jacobsen; Riddhi D Patel; Judith C McCaffrey; Jason A Oliver; Steven K Sutton; Thomas H Brandon Journal: Cancer Date: 2012-12-20 Impact factor: 6.860
Authors: Daisuke Kawakita; Sarah Abdelaziz; Yuji Chen; Kerry Rowe; John Snyder; Alison Fraser; Ken Smith; Kimberly Herget; Vikrant Deshmukh; Michael Newman; Marcus Monroe; Mia Hashibe Journal: Cancer Date: 2019-11-13 Impact factor: 6.860
Authors: Úrsula Martínez; Karen O Brandon; Steven K Sutton; Thomas H Brandon; Vani N Simmons Journal: Psychooncology Date: 2019-07-02 Impact factor: 3.894
Authors: Andrew Miele; Morgan Thompson; Nancy C Jao; Ravi Kalhan; Frank Leone; Lee Hogarth; Brian Hitsman; Robert Schnoll Journal: J Addict Date: 2018-02-26